Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Banco Santander SA (SAN) vs Smith & Nephew plc (SNN) Price & Performance

Banco Santander SATrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Banco Santander SA vs Smith & Nephew plc — how do they compare? Banco Santander SA trades at $13.7 (market cap $191.46B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Banco Santander SA is far larger — about 15.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.

SANSNN
Market Cap
$191.46B$12.64B
Sector
FinancialsHealth
52-Week High
$14.37$38.70
52-Week Low
$8.40$28.73
Dividend Yield
2.09%2.57%
Enterprise Value
$15.41B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Banco Santander SA

Santander (SAN) trades at $13.65, up 0.74% with mixed technical signals showing bearish moving averages but oversold RSI. The company reported Q1 2026 EPS beat ($0.41 vs $0.29 expected) and maintains strong profitability with 26.72% net margin and 16.18% ROE. Recent developments include the $12.2 billion Webster Bank acquisition and AI-driven cost initiatives targeting $1.15 billion in business value.

SAN offers value with a 13.23 P/E and dividend yield near 4.4%, supported by 64% analyst buy ratings. Key risks include declining cash flows (-$28.13B in 2024) and Spanish antitrust probes. The stock's upside depends on successful integration of acquisitions and AI efficiency gains offsetting macroeconomic pressures on European banking.

Smith & Nephew plc

SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.

Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.

Returns comparison

Trailing returns across standard periods

About Banco Santander SA

Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.

Read more on SAN

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN